12 Health Care Stocks Moving In Friday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Friday's pre-market session, several healthcare stocks experienced significant movements. Mesoblast (MESO) saw a 22.1% increase, while Sangamo Therapeutics (SGMO) rose by 20.27%. Telesis Bio (TBIO) and INVO Bioscience (INVO) also saw gains of 19.27% and 17.43%, respectively. Coherus BioSciences (CHRS) and TC BioPharm (TCBP) shares increased as well. On the downside, Esperion Therapeutics (ESPR) fell by 17.7%, Adial Pharmaceuticals (ADIL) by 15.47%, Accelerate Diagnostics (AXDX) by 10.91%, Alaunos Therapeutics (TCRT) by 9.47%, Nuwellis (NUWE) by 9.12%, and MorphoSys (MOR) by 8.7%.
January 19, 2024 | 1:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Mesoblast shares surged 22.1% in pre-market trading, indicating strong investor interest.
A significant pre-market increase often leads to continued momentum after the market opens, as early gains can attract more investor attention.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Sangamo Therapeutics' stock rose by 20.27%, reflecting positive sentiment among investors.
The substantial pre-market rise suggests that the stock may continue to perform well in the short term, possibly due to recent company developments or market conditions.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 90
NEGATIVE IMPACT
Adial Pharmaceuticals' stock declined by 15.47%, which may reflect investor skepticism or negative news.
The pre-market drop could suggest a bearish outlook for the stock in the short term, potentially due to company-specific issues or broader market trends.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 90
NEGATIVE IMPACT
Esperion Therapeutics' stock fell 17.7%, indicating potential concerns or negative developments.
A sharp decline in pre-market can often carry over into regular trading hours, especially if driven by negative news or market sentiment.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90